+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

S

Actively Recruiting

This research aims to evaluate whether giving plasma from a donor who had a Chikungunya infection within the past six months to newborns whose mothers had a peripartum Chikungunya infection can improve the chances that newborns survive without brain inflammation or damage within the first five days of life. The study compares this treatment group to an observational group of newborns who did not receive the plasma transfusion due to diagnosis or hospital transfer delays or parental refusal. Newborns in the treatment group receive a plasma transfusion and are monitored with medical and biological tests every day for the first seven days, plus a follow-up visit between one and three months of age. The observational group receives no intervention but has their medical data collected during standard care from the mothers diagnosis until the newborn reaches three months. Participants undergo daily clinical examinations and biological tests during the first week and one visit between one and three months. Researchers will measure the effectiveness of early plasma transfusion in preventing brain inflammation or damage within five days after inclusion. The study involves close monitoring and data collection to assess outcomes and safety over the newborns first few months.

Age: 0Days - 2DaysAll GendersPhase Not Applicable
3 locations
S

Actively Recruiting

Healthy Volunteer

Researchers are studying automated fetal heart function parameters to see if they differ between healthy babies and those with congenital heart disease. This international multicenter observational study aims to find out if these automated measurements can better predict heart complications like hydrops compared to current cardiovascular scores. The study focuses on pregnancies with and without fetal heart defects to compare cardiac function over time. Participants will have two fetal cardiac function ultrasound scans one between 27 weeks and 29 weeks plus 6 days of pregnancy, and another between 34 weeks and 36 weeks plus 6 days. These scans use both clinical and advanced research ultrasound systems to capture detailed heart measurements, including heart size, valve function, blood flow, and contractility. The study collects images and data securely and follows participants until delivery and hospital discharge. During the study, women will undergo standard pregnancy ultrasounds alongside research scans assessing various heart function parameters. Researchers will analyze these detailed images and functional data to compare healthy and affected fetuses. They will also evaluate if adding automated measures improves prediction of complications like hydrops. Data confidentiality is maintained, and results will be published while protecting patient privacy. The entire pregnancy period is observed, with data collected at two specific gestational windows.

Age: 18Years +FEMALE
7 locations